Hariprasad Chandran

Hariprasad Chandran is a highly experienced professional in the field of pharmacovigilance, currently serving as the Director of Pharmacovigilance at ICON plc since November 2020. Prior roles include Senior Manager and Manager at Samsung Bioepis from October 2016 to October 2020, Associate Principal at Foresight Group International AG, and various positions at Aris Global and ICON Clinical Research. Hariprasad gained foundational experience as a Senior Process Associate at Accenture. Educational credentials include an M.Sc in Clinical Research from Cranfield University and a B.Sc in Biotechnology, Genetics, and Chemistry from Bangalore University. Hariprasad's expertise encompasses a comprehensive understanding of pharmacovigilance frameworks across multiple regions, including the US, Europe, and Japan.